Results 21 to 30 of about 413,336 (178)
Interleukin-38 and cardiovascular pathology: literature review [PDF]
КардиоСоматика, 2023 Cardiovascular pathology is a leading cause of morbidity and mortality. An important task of modern cardiology is the search and study of new biological markers. Scientists’ interest is actively focused on the study of interleukin-38.
Amina M. Alieva +4 more
doaj +1 more source
Retraction ‘Reduced interleukin-38 in non-small cell lung cancer is associated with tumour progression’ [PDF]
Open Biology, 2020 Feng Wang +3 more
doaj +2 more sources
Pifu-xingbing zhenliaoxue zazhi, 2023 Objective To investigate the roles of cytokines, IL-36γ and IL-38, in the inflammatory response in psoriasis vulgaris. Methods Both serum and peripheral blood mononuclear cells (PBMC) were collected from 29 patients with psoriasis vulgaris (PV) and 19 ...
Jiao ZHANG +4 more
doaj +1 more source
Journal of the Egyptian Women’s Dermatologic Society, 2023 Background In psoriasis, interleukin (IL)-36 is considered a pathogenic driver, whereas IL-38 was downregulated. Little is known about their role in metabolic syndrome (Ms) in psoriasis.
Marwa A Amer +6 more
doaj +1 more source
IL‐38 attenuates myocardial ischemia–reperfusion injury by inhibiting macrophage inflammation
Immunity, Inflammation and Disease, 2023 Background Reperfusion therapy is the most effective approach to resolve coronary occlusion, but myocardial injury caused by excessive inflammation during myocardial ischemia–reperfusion will also pose a new threat to health. Our prior study revealed the
Yuzhen Wei +6 more
doaj +1 more source
Anti-inflammatory Mechanisms of IL-38 in Chinese Patients with Allergic Rhinitis [PDF]
Iranian Journal of Immunology, 2023 Background: T-helper 17 (Th17) cell response is engaged in the onset of allergic rhinitis (AR). Moreover, interleukin (IL)-38 is thought to be involved in inhibiting cytokine secretion in the Th17 pathway.Objective: To evaluate the regulatory function of
Xiaoqiang Wang +3 more
doaj +1 more source
The emerging role of IL‐38 in diseases: A comprehensive review
Immunity, Inflammation and Disease, 2023 Introduction Interleukin‐38 (IL‐38) is a new type of anti‐inflammatory cytokine, which is mainly expressed in the immunity‐related organs and is involved in various diseases including cardiovascular and cerebrovascular diseases, lung diseases, viral ...
Weijun Chen +3 more
doaj +1 more source
Cellular Physiology and Biochemistry, 2018 Background/Aims: Hyperlipidemia is a risk factor for various cardiovascular and metabolic disorders. And it is tightly related to chronic inflammation. Interleukin-38 (IL-38) represents a new member of anti-inflammatory cytokines.
Ning Yang +6 more
doaj +1 more source
Serum interleukin 38 (IL-38) as a new potential biomarker of pediatric asthma
The Egyptian Journal of Bronchology, 2022 Background Bronchial asthma is considered the most prevalent chronic respiratory disease worldwide and is one of the main causes of hospitalization in the pediatric population.
Asmaa Kamal +3 more
doaj +1 more source
The Pathological Mechanism and Potential Application of IL-38 in Autoimmune Diseases
Frontiers in Pharmacology, 2021 Interleukin-38 (IL-38), a new cytokine of interleukin-1 family (IL-1F), is expressed in the human heart, kidney, skin, etc. Recently, new evidence indicated that IL-38 is involved in the process of different autoimmune diseases. Autoimmune diseases are a
Miao-miao Han +12 more
doaj +1 more source